binance left Coinmarketcap net_left adver left
Detail

GSK rejects 50-billion-pound Unilever offer for consumer assets

By Siddharth Cavale, Ludwig Burger and Mrinmay Dey (Reuters) -GlaxoSmithKline on Saturday said it had rejected a 50-billion-pound offer from Unilever (NYSE:UL) for its consumer...

By Siddharth Cavale, Ludwig Burger and Mrinmay Dey

(Reuters) -GlaxoSmithKline on Saturday said it had rejected a 50-billion-pound offer from Unilever (NYSE:UL) for its consumer goods arm, saying it "fundamentally undervalued" the business and its future prospects and that it would stick to its plan of spinning off the unit.

Unilever confirmed the approach earlier on Saturday, saying the Glaxo unit would be a "strong strategic fit" as it continues to re-shape its portfolio spanning food, beauty and home care brands.

A deal of this size would be the biggest globally since the start of the pandemic, if it goes through. It could also transform Unilever into a formidable beauty and personal care purveyor, taking on the likes of Estee Lauder (NYSE:EL) and L'Oreal, while for GSK, it could bring much needed relief from investor pressure that has been building over the past year.

GSK said it had received three bids from Unilever, the latest on Dec. 20 comprising 41.7 billion pounds in cash and 8.3 billion pounds in Unilever shares, which failed to reflect the intrinsic value of the business and its potential.

"The Board of GSK therefore remains focused on executing its proposed demerger of the Consumer Healthcare business ... on track to be achieved in mid-2022," the statement said, adding that it was confident the business would beat global market growth rates in the medium term.

The group's consumer goods business is due to be spun out into a separate listing in the middle of this year.

Earlier, Britain's Sunday Times said the Unilever bid for the business made late last year was worth roughly 50 billion pounds, and had been rejected as too low by GSK and Pfizer (NYSE:PFE), which owns a minority stake in the division.

The approach by Unilever, which owns brands such as Dove soap and Marmite, for Glaxo's portfolio of household brands including Panadol painkillers and Sensodyne toothpaste was understood to have been unsolicited, the report added.

The bid did not include any takeover premium or recognition of synergies, the newspaper said, adding that it was not clear whether the group would make a higher offer.

Dave Lewis, who is due to head GSK's consumer health unit, declined to comment on the approach. The former boss of UK grocer Tesco (OTC:TSCDY) said the matter was for GSK's board.

Unilever declined to comment on whether it would return with a higher bid. "There can be no certainty that any agreement will be reached." Brokerage Jefferies last year put a valuation for the whole consumer unit at 45 billion pounds.

If a deal goes through, GSK's consumer health unit's brands would likely be incorporated into Unilever's Beauty and Personal Care business, its biggest by sales.

Performance in the unit, which sells Dove, Lifebuoy, Axe and Vaseline, has been tepid during the pandemic as fewer people venture out or attend social occasions, while higher costs of plastics and petrochemicals have also dented margins.

In its most recent quarter, Beauty and Personal care volumes fell 1.3% while prices rose 3.9%.

INVESTOR PRESSURE

Unilever's Chief Executive Alan Jope is under pressure to turn around its languishing stock price as it struggles to compete in the face of high inflationary costs, especially in emerging markets, its biggest source of revenue.

The FTSE-listed conglomerate's stock has fallen 10% over the past year compared with P&G's 18% rise and Reckitt's 1.4% decline, despite a pandemic-driven boost in shopping for groceries and household goods that has benefited all three companies.

British fund manager Terry Smith, whose Fundsmith vehicle is a top-10 Unilever investor, this week criticized the group for promoting sustainability credentials at the expense of performance.

Since taking over from Paul Polman as CEO in 2019, Jope has laid out a vision for Unilever called "brands with purpose", a socially conscious strategy that would see the company focus investments and marketing on brands that "communicate a strong environmental or social purpose" even at the cost of profit.

"A company which feels it has to define the purpose of Hellmann’s mayonnaise has in our view clearly lost the plot. The Hellmann’s brand has existed since 1913 so we would guess that by now consumers have figured out its purpose (spoiler alert — salads and sandwiches)," Smith said.

Smith was not immediately available to comment.

Jope, however, has kept to his promise of streamlining the company. The company sold a majority of its Tea business, including Pukka Tea and PGTips to CVC Capital partners for $5 billion late last year and has been looking to offload a portfolio of slow growing beauty brands.

Investor activism has also reared its head at GSK.

In April last year, U.S. activist hedge fund Elliott Management revealed a multi-billion pound stake in GSK, putting pressure on CEO Emma Walmsley to explore a shake-up of the company after it fell behind in the COVID-19 vaccine race.

Fledgling activist investor Bluebell Capital Partners, fresh off its success in ousting the CEO of Danone last year, also took a stake in GSK in September, making demands including asking Walmsley to re-apply for her job, citing a lack of scientific expertise.

BIG DEAL FOR JOPE

For Unilever, the deal would be the biggest move for Jope since becoming CEO in 2019.

He has previously shot down suggestions that Unilever was in the market for big deals, saying instead that the company would focus on smaller acquisitions in fast-growing areas such as luxury beauty, plant-based foods and health and wellness.

If a deal with GSK does go through, it will be Unilever's second with the company after it bought its health food drinks business, including Horlicks, in India and other Asian markets for 3.3 billion euros in 2018.

The consumer remedies industry, which has traditionally been attached to the prescription drug sector, is also in a phase of major transformation as several pharma companies no longer see a benefit in a combination.

Johnson & Johnson (NYSE:JNJ) in November unveiled plans to spin off its consumer health division, owner of the Listerine and Baby Powder brands, to focus on pharmaceuticals and medical devices. Sanofi (NASDAQ:SNY) has said its consumer unit would become “standalone” business.

($1 = 0.7314 pounds)

ig right nyse right Neteller adver right
APPROVED BROKERS
rakuten_main right top net_home_top ig_main right top Binance _ main right top fbs_main right top tifia_main right top
21-01-2022 04:12:29 (UTC+7)

EUR/USD

1.1337

+0.0027 (+0.24%)

Summary

Neutral

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (4)

Sell (3)

EUR/USD

1.1337

+0.0027 (+0.24%)

Summary

Neutral

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (4)

Sell (3)

GBP/USD

1.3564

-0.0031 (-0.23%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

USD/JPY

113.94

-0.14 (-0.13%)

Summary

Sell

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (0)

Sell (9)

AUD/USD

0.7186

-0.0039 (-0.53%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (10)

USD/CAD

1.2531

+0.0029 (+0.23%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

EUR/JPY

129.18

+0.14 (+0.11%)

Summary

↑ Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (0)

Sell (9)

EUR/CHF

1.0356

-0.0008 (-0.08%)

Summary

Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (1)

Sell (3)

Gold Futures

1,831.25

-11.35 (-0.62%)

Summary

Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (3)

Sell (3)

Silver Futures

24.363

-0.353 (-1.43%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (1)

Sell (9)

Copper Futures

4.5237

-0.0588 (-1.28%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (1)

Sell (7)

Crude Oil WTI Futures

83.87

-1.68 (-1.96%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

Brent Oil Futures

86.80

-1.58 (-1.79%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

Natural Gas Futures

3.925

+0.123 (+3.24%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (0)

Sell (8)

US Coffee C Futures

242.75

-1.70 (-0.70%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (10)

Euro Stoxx 50

4,237.45

-62.16 (-1.45%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (1)

Sell (7)

S&P 500

4,482.73

-50.03 (-1.10%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (0)

Sell (8)

DAX

15,673.31

-239.02 (-1.50%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

FTSE 100

7,512.57

-72.44 (-0.96%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (2)

Sell (7)

Hang Seng

24,965.55

+13.20 (+0.05%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (5)

Sell (0)

US Small Cap 2000

2,024.04

-38.75 (-1.88%)

Summary

↑ Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (2)

Sell (7)

IBEX 35

8,678.04

-136.56 (-1.55%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (1)

Sell (7)

BASF SE NA O.N.

66.260

-1.180 (-1.75%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

Bayer AG NA

51.84

-0.86 (-1.63%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

Allianz SE VNA O.N.

221.08

-3.72 (-1.65%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

Adidas AG

254.66

-0.99 (-0.39%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (1)

Sell (8)

Deutsche Lufthansa AG

6.918

-0.175 (-2.47%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (6)

Siemens AG Class N

145.53

-1.37 (-0.93%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (1)

Sell (5)

Deutsche Bank AG

11.535

-0.141 (-1.21%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

 EUR/USD1.1337Neutral
 GBP/USD1.3564↑ Sell
 USD/JPY113.94Sell
 AUD/USD0.7186↑ Sell
 USD/CAD1.2531↑ Buy
 EUR/JPY129.18↑ Sell
 EUR/CHF1.0356Sell
 Gold1,831.25Sell
 Silver24.363↑ Sell
 Copper4.5237↑ Sell
 Crude Oil WTI83.87↑ Sell
 Brent Oil86.80↑ Sell
 Natural Gas3.925↑ Sell
 US Coffee C242.75↑ Sell
 Euro Stoxx 504,237.45↑ Sell
 S&P 5004,482.73↑ Sell
 DAX15,673.31↑ Sell
 FTSE 1007,512.57↑ Sell
 Hang Seng24,965.55↑ Buy
 Small Cap 20002,024.04↑ Sell
 IBEX 358,678.04↑ Sell
 BASF66.260↑ Sell
 Bayer51.84↑ Sell
 Allianz221.08↑ Sell
 Adidas254.66↑ Sell
 Lufthansa6.918↑ Sell
 Siemens AG145.53↑ Sell
 Deutsche Bank AG11.535↑ Sell
Mua/Bán 1 chỉ SJC
# So hôm qua # Chênh TG
SJC Eximbank6,120/ 6,160
(5/ 5) # 1,137
SJC HCM6,115/ 6,175
(5/ 5) # 1,154
SJC Hanoi6,115/ 6,177
(5/ 5) # 1,156
SJC Danang6,115/ 6,177
(5/ 5) # 1,156
SJC Nhatrang6,115/ 6,177
(5/ 5) # 1,156
SJC Cantho6,115/ 6,177
(5/ 5) # 1,156
Cập nhật 21-01-2022 04:12:33
Xem lịch sử giá vàng SJC: nhấn đây!
ↀ Giá vàng thế giới
$1,831.96-7.13-0.39%
Live 24 hour Gold Chart
ʘ Giá bán lẻ xăng dầu
Sản phẩmVùng 1Vùng 2
RON 95-IV2486025350
RON 95-II,III
E5 RON 92-II2359024060
DO 0.05S1890019270
DO 0,001S-V1925019630
Dầu hỏa1779018140
ↂ Giá dầu thô thế giới
WTI$83.82+1.862.22%
Brent$86.77+1.361.57%
$ Tỷ giá Vietcombank
Ngoại tệMua vàoBán ra
USD22.450,0022.760,00
EUR24.965,0926.364,70
GBP29.963,4031.243,06
JPY192,94204,24
KRW16,3919,97
Cập nhật lúc 16:09:54 21/01/2022
Xem bảng tỷ giá hối đoái
binance main right Fxpro Main Right aetos main right adver main right